QUIDELORTHO CORP Payments to Acquire Marketable Securities
QUIDELORTHO CORP (QDEL) reported Payments to Acquire Marketable Securities of $0 for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-19.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2026-02-19
- QUIDELORTHO CORP payments to acquire marketable securities for the quarter ending 2025-12-28 was $0.00.
- QUIDELORTHO CORP payments to acquire marketable securities for the quarter ending 2025-09-28 was $0.00.
- QUIDELORTHO CORP payments to acquire marketable securities for the quarter ending 2025-06-29 was $0.00.
- QUIDELORTHO CORP payments to acquire marketable securities for the quarter ending 2025-03-30 was $0.00, a 100.00% decline year-over-year.
- QUIDELORTHO CORP payments to acquire marketable securities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- QUIDELORTHO CORP payments to acquire marketable securities for fiscal 2024 was $7.20M, a 88.02% decline from fiscal 2023.
- QUIDELORTHO CORP payments to acquire marketable securities for fiscal 2023 was $60.10M, a 5.65% decline from fiscal 2023.
- QUIDELORTHO CORP payments to acquire marketable securities for fiscal 2023 was $63.70M, a 5.49% decline from fiscal 2022.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2025-12-28 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 10-K · filed 2026-02-19 |
| 2025-09-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $0.00 10-Q · filed 2025-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2025-03-30 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $0.00 derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $0.00 derived: sum of 2 quarters · filed 2026-02-19 | $0.00 derived: sum of 3 quarters · filed 2026-02-19 | $7.20M 10-K · filed 2026-02-19 |
| 2024-09-29 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $7.20M 10-Q · filed 2025-11-06 | $16.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $7.20M 10-Q · filed 2025-08-06 | $16.70M derived: sum of 3 quarters · filed 2026-02-19 | $16.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $7.20M 10-Q · filed 2025-05-08 | $16.70M derived: sum of 2 quarters · filed 2026-02-19 | $16.70M derived: sum of 3 quarters · filed 2026-02-19 | $35.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.50M derived: sum of 2 quarters · filed 2026-02-19 | $28.50M derived: sum of 3 quarters · filed 2026-02-19 | $60.10M 10-K · filed 2026-02-19 |
| 2023-10-01 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $19.00M derived: sum of 2 quarters · filed 2024-11-08 | $50.60M 10-Q · filed 2024-11-08 | $64.90M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | $19.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $50.60M 10-Q · filed 2024-08-01 | $64.90M derived: sum of 3 quarters · filed 2025-02-27 | $80.70M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $31.60M 10-Q · filed 2024-05-09 | $45.90M derived: sum of 2 quarters · filed 2025-02-27 | $61.70M derived: sum of 3 quarters · filed 2025-02-27 | $79.40M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $14.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $30.10M derived: sum of 2 quarters · filed 2025-02-27 | $47.80M derived: sum of 3 quarters · filed 2025-02-27 | $63.70M 10-K · filed 2025-02-27 |
| 2022-10-02 | $15.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $33.50M derived: sum of 2 quarters · filed 2023-11-02 | $49.40M 10-Q · filed 2023-11-02 | $116.80M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $17.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $33.60M 10-Q · filed 2023-08-09 | $101.00M derived: sum of 3 quarters · filed 2024-08-01 | $101.00M derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $15.90M 10-Q · filed 2023-05-04 | $83.30M derived: sum of 2 quarters · filed 2024-08-01 | $83.30M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $67.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $67.40M derived: sum of 2 quarters · filed 2024-08-01 | $67.40M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $0.00 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $0.00 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $0.00 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |